Step towards a healthier life

The COPLA Scaffold

A regenerative solution for cartilage repair

The COPLA ScaffoldTM is a 3D biodegradable composite of polylactide and non-animal derived collagen for cartilage repair in weight bearing joints.

The COPLA ScaffoldTM can be used in different cartilage locations, in different species, and for full thickness chondral or osteochondral lesions. The COPLA ScaffoldTM is only available for animal healthcare.

Biological benefits

  • Fills the lesion immediately with load adaptive matrix
  • The patient can immediately bear weight on the operated limb
  • Provides ideal environment for hyaline cartilage regeneration

Technical benefits

  • Highly porous and biodegradable structure
  • One step procedure
  • Easy to cut and shape into the desired form
  • Easy to fix with fibrin glue or sutures

From Finland

With passion to make a difference


Our mission is to provide evidence-based orthopedic treatments to veterinary surgeons globally. The COPLA ScaffoldTM is the most effective solution for cartilage repair and prevention of osteoarthritis and could benefit tens of thousands of animal patients each year.


The solid scientific background of the team provides in-depth understanding of the challenges of cartilage repair. Askel Healthcare does not stop at treating symptoms; we go a step* further and provide truly regenerative solutions for the long-term benefit of the patients.

*Step = Askel (in Finnish)


Askel Healthcare was founded by experienced scientists from the fields of tissue engineering, material science, cell biology, and orthopedics. The research team had one goal: to provide a solution for the unmet medical need of cartilage regeneration. The team has what it takes to treat cartilage lesions for a large group of patients around the world. Askel Healthcare was established through innovativeness, passion, and care for all creatures.


The technology of the COPLA ScaffoldTM is well suited to treat many species including human beings. Making our solutions available for human medicine is a long-term project that we want to achieve in the most ethical way. One of the goals of Askel Healthcare is to explore the possibility to expedite human market access by utilizing the clinical results from veterinary use, and thus create a true interspecies partnership.




Virpi Muhonen

CEO & Co-founder

+358 40 489 3840
Anne-Marie Haaparanta

CTO & Co-founder

+358 40 489 3843
Constance Trouvé

Sales and marketing manager

+358 40 489 3844

Askel Healthcare Ltd

Kuortaneenkatu 2
00510 Helsinki
VAT FI28180584                                                 
                                                                                   © Askel Healthcare Ltd. All rights reserved.